The effect of combined therapy with statins and levothyroxine on the lipid profile dynamics in patients with a comorbid course of arterial hypertension, type 2 diabetes mellitus and subclinical hypothyroidism

Abstract

To date, there are no sufficiently clear recommendations for the management of patients with the TSH level between the upper limit of the control range and 10.0 mIU/L, and with a high cardiovascular risk (CVR). Aim. To assess the effect of combined therapy with statins and levothyroxine on the state of lipid metabolism and total CVR in patients with comorbid course of arterial hypertension (AH), type 2 diabetes mellitus (T2DM) and subclinical hypothyroidism (SHT). Materials and methods. 67 patients aged 44 to 75 years with the stage II AH, T2DM and SHT were included. All patients used statins prior to inclusion in the study. At the TSH level of more than 6.0 μMU/ml levothyroxine was additionally prescribed in individually selected doses from 12.5 to 50 μg/day. Lipid and thyroid metabolism indexes, the concentration of C-reactive protein (CRP) and the tumor necrosis factor-α (TNF-α) were measured by standard methods. The period of observation was 12 months. Results. Patients with TSH levels of >6.0 μMU/ml, despite statin therapy, have more pronounced dyslipidemia, higher CRP values (p<0.05) and a tendency to increase TNF-α (p>0.05). The additional use of levothyroxine led to a significant decrease in total cholesterol (p=0.011), low-density lipoprotein cholesterol (p=0.025), and a highly significant decrease in CRP and TNF-α (p<0.001). Conclusions. Combined therapy, including statins and levothyroxine, leads to more significant improvement in the lipid profile than statins without the replacement therapy, a decrease in the signs of systemic inflammation, and, in the aggregate, has a positive effect on the total cardiovascular risk in this category of patients.

Authors and Affiliations

V. D. Nemtsova, О. M. Ievtushenko, V. V. Chaikovska

Keywords

Related Articles

The analysis of the components in modern shampoos for children with the aim of further development of domestic products

Proper care that is adequate to the condition of the newborn’s skin and hair is the necessary condition for maintaining health, preventing possible allergic manifestations and various diseases. The main components of a d...

Теоретичне обґрунтування пошуку потенційних лікарських засобів, що містять біологічно активні речовини з сировини харчових рослин

Зважаючи на те, що харчові рослини мають стабільну сировинну базу і доведену нешкідливість для організму людини, використання сировини харчових рослин для створення нових ЛЗ є актуальним та має низку переваг: достатню си...

The scientific and practical substantiation of the therapeutic drug monitoring procedure: validation of the analytical method of valproic acid measurement

The need for careful therapeutic drug monitoring (TDM) arises for measurement of drugs with a narrow therapeutic index (NTIDs), as well as for assuring their safe and controlled replacement with generics. In particular,...

Розробка умов аналітичної діагностики отруєнь атомоксетином

Атомоксетин є одним з основних лікарських препаратів для лікування синдрому дефіциту уваги і гіперактивності. Препарат неодноразово був причиною летальних отруєнь. Дані з визначення атомоксетину в біологічному матеріалі...

Теоретическое обоснование поиска потенциальных лекарственных средств, содержащих биологически активные вещества из сырья пищевых растений

Учитывая то, что пищевые растения имеют стабильную сырьевую базу и доказанную безвредность для организма человека, использование сырья пищевых растений для создания новых лекарственных средств является актуальным и имеет...

Download PDF file
  • EP ID EP659790
  • DOI 10.24959/cphj.19.1502
  • Views 78
  • Downloads 0

How To Cite

V. D. Nemtsova, О. M. Ievtushenko, V. V. Chaikovska (2019). The effect of combined therapy with statins and levothyroxine on the lipid profile dynamics in patients with a comorbid course of arterial hypertension, type 2 diabetes mellitus and subclinical hypothyroidism. Клінічна фармація; Клиническая фармация, 23(3), 57-63. https://europub.co.uk./articles/-A-659790